Quote:
Originally Posted by Victor H
NEW TYSABRI USERS:
Biogen is enrolling 2,500 people in a trial wheren they want to monitor long-term Tysabri user progress over a 5 year period. You cannot have more than 3 infusions under your belt so far, thus we long-term users cannot participate.
Contact the NMSS for details.
-Vic
|
From reading the article, the trial is being conducted to monitor the safety aspect of Tysabri. It didn't mention any data being collected to show what benefit the patients may or may not be getting from taking the drug.
I would hope that patients who have to quit using the drug because of side effects or other problems will end up in the data at the end of 5 years.
Harry